What is Sales and Marketing Strategy of Aurora Company?

How did Aurora pivot to become a medical cannabis leader?

The company shifted from a scale-first cultivation model to focus on high-margin medical markets and operational efficiency, reaching positive free cash flow in late 2024. Founded in 2013 in Edmonton, Aurora refocused on genetics, science and global medical expansion.

Aurora now operates in about 15 countries with strong Canadian medical market share, using specialized distribution, data-driven medical marketing and scientific positioning to compete in complex regulations.

What is Sales and Marketing Strategy of Aurora Company? Short answer: targeted medical channels, clinician engagement, evidence-led messaging and geographic diversification; see Aurora Porter's Five Forces Analysis for related strategic context.

Aurora employs a multi-channel sales strategy prioritizing high-margin medical exports and direct-to-patient platforms, with the global medical channel driving the majority of revenue. In fiscal 2025 the medical channel represented approximately 75–80% of cannabis net revenue, supported by strong international footprints and a focused Canadian e-commerce model.

Medical Export Channel

Aurora's primary revenue driver is the global medical channel, leveraging high-margin exports to Europe and other regulated markets. Germany operations contribute materially via specialized pharmacies and wholesalers.

Direct-to-Patient Canada

In Canada Aurora serves the largest medical patient base through a direct-to-patient e-commerce storefront, increasing margins by bypassing retail intermediaries and reducing distribution cost.

Adult-Use Recreational

Recreational sales in Canada are managed via provincial wholesalers (OCS, BCLDB), with a shift toward premium craft flower and high-potency extracts instead of low-margin bulk products.

Diversified Agri Channel

The acquisition of Bevo Farms adds a greenhouse propagation and vegetable channel, providing revenue diversification and partial hedging against cannabis market volatility.

These channels combine into an omnichannel go-to-market approach that emphasizes medical sales while maintaining consumer market presence and new revenue streams.

Channel Performance Highlights

Key metrics and strategic points for Aurora's sales channels in fiscal 2025.

• Global medical channel: 75–80% of cannabis net revenue in fiscal 2025.
• Germany: top-three market share position post-CanG Act regulatory easing in 2024.
• Canadian direct-to-patient e-commerce: largest medical patient base in Canada; higher gross margins via direct fulfillment.
• Recreational channel: focus on premium and high-potency SKUs through provincial wholesalers (OCS, BCLDB).

For a deeper examination of corporate strategy and growth initiatives see Growth Strategy of Aurora.

Complete Aurora Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Marketing Tactics at Aurora prioritize educational content and healthcare provider engagement to comply with strict cannabis advertising regulations, using data from Aurora Medical to drive targeted outreach and patient retention.

Educational Content

Deep medical content focused on conditions and therapeutic benefits, optimized for SEO to capture clinical searches and patient intent.

Healthcare Provider Webinars

Regular webinars for physicians and pharmacists to present clinical data, dosing guidance and safety profiles.

White Papers & Research

Published white papers on cannabinoid research to build clinical credibility and support sales conversations.

Patient Portal

Comprehensive portal providing personalized strain recommendations using historical usage data and clinical profiles.

CRM & Retention

Increased CRM investment in 2025 to boost retention; achieved a 15 percent increase in repeat order frequency year-over-year.

Professional Outreach

Targeted presence at medical conferences and partnerships with clinics; specialized sales force engages pharmacists and doctors internationally.

Targeted analytics ensure spend favors high-LTV medical patients and measures funnel effectiveness across channels.

Execution & Metrics

Key tactics link digital education to clinical sales, with measurable KPIs and international field teams focusing on clinical trust and repeat prescriptions.

• SEO targeting medical conditions and therapeutic benefits to improve organic visibility for patient queries.
• Webinars, white papers and conference presentations to support Aurora Company sales strategy and Aurora Company marketing strategy.
• CRM-driven retention programs yielding a 15 percent uplift in repeat orders in 2025 versus prior year.
• Advanced analytics track educational funnel conversion and prioritize high lifetime-value medical patients over one-time recreational buyers.

Channels and outreach are aligned with the Aurora Company go to market strategy, sales process and customer acquisition goals, feeding into product distribution and sales team structure while avoiding traditional advertising due to compliance risks; further details on commercial model are available at Revenue Streams & Business Model of Aurora

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

Aurora positions itself as the scientific authority in the cannabis sector, prioritizing medical excellence, genetic research and clinical validation to differentiate from lifestyle-focused competitors. The brand emphasizes reliability, consistency and transparency to appeal to healthcare professionals and patients seeking therapeutic solutions.

Scientific Authority

Aurora Company sales strategy centers on clinical credibility, leveraging Occasio and genetics programs to develop proprietary cultivars with targeted terpene and cannabinoid profiles for medical use.

Clinical Visual Identity

Visual identity is clean and clinical to resonate with clinicians and patients; packaging and comms prioritize data, lab reports and EU-GMP certification badges.

Consistency & Transparency

Brand promise anchored in batch-to-batch consistency, third-party testing and transparent labeling to support international medical distribution and payer confidence.

Regulatory Credentials

EU-GMP and similar certifications underpin Aurora Company marketing strategy for export markets; such credentials reduce market-entry friction for medical channels.

The brand leverages sustainability and innovation narratives—highlighting its 2025 sustainability goals and leadership in cannabinoid science—to strengthen Aurora Company go to market strategy and customer acquisition among institutional buyers.

Product Portfolio Evolution

Aurora Company sales process adapts by expanding into convenient delivery formats such as softgels and rapid-onset edibles to meet patient preference and prescriber demand.

Genetics & R&D

Occasio and genetics programs aim to produce cultivars with reproducible terpene/cannabinoid fingerprints; R&D spend rose in recent years to support clinical pipelines and formulation work.

Market Differentiation

Medical-first positioning creates higher barriers to entry versus recreational brands, producing stronger brand stickiness among patients and institutional purchasers.

Sales & Distribution

Distribution focuses on pharmacies, clinics and export channels; EU-GMP support enables access to European and other regulated markets for medical cannabis.

Brand Loyalty Metrics

Medical positioning often yields higher repeat-purchase rates; industry data through 2025 shows medical channels reporting up to 30% higher retention versus recreational segments.

Digital & Content Strategy

Content and digital marketing emphasize clinical evidence, patient outcomes and HCP education to support Aurora Company digital marketing approach and lead generation strategy.

Key Strategic Imperatives

Brand positioning activities map directly to sales and marketing KPIs to drive trust and adoption in medical markets.

• Prioritize clinical validation and EU-GMP credentialing for international distribution
• Leverage proprietary genetics to offer differentiated, reproducible products
• Expand delivery formats (softgels, rapid-onset edibles) to improve patient adherence
• Use educational content to support Aurora Company sales team structure and customer acquisition

For a deeper look at tactical marketing execution and market positioning, see Marketing Strategy of Aurora

Aurora Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Key Campaigns in 2025 focused on regulatory-driven medical expansion and R&D-led commercialisation, delivering measurable revenue and market-share gains across Europe and international wholesale channels.

German Medical Expansion

The campaign targeted over 10,000 healthcare practitioners after Germany reclassified cannabis as non-narcotic, combining digital education and in-person seminars to simplify prescribing of EU-GMP certified products.

Impact on Medical Revenue

International medical revenue increased by over 30% year-over-year in H1 2025, positioning the company as a preferred partner for German pharmacies under the new regulatory framework.

Genetics First Program

Short-form video and interactive digital catalogs highlighted the breeding program and R&D capabilities, driving a 25% increase in wholesale genetics sales to international partners.

Patient First Initiative

Streamlined medical documentation and compassionate pricing for veterans and low-income patients reinforced social responsibility and improved patient access in medical channels.

These campaigns advanced the Aurora Company sales strategy and Aurora Company marketing strategy by blending regulatory advocacy, clinician education, digital content marketing and commercial partnerships to optimise customer acquisition and sales funnel conversion.

Targeting and Reach

German Medical Expansion reached >10,000 prescribers via webinars, CRM-driven email and regional seminars to accelerate adoption among pharmacies and clinicians.

Content & Digital Approach

Genetics First used short-form video and interactive catalogs for B2B lead generation and to support the Aurora Company digital marketing approach across international markets.

Sales Outcomes

H1 2025 international medical revenue rose >30%, while wholesale genetics sales grew 25%, evidencing effective Aurora Company sales process optimisation.

Market Positioning

Campaigns strengthened brand equity and competitive positioning, supporting distribution channel expansion and partner preference in Europe.

Social Responsibility

Patient First improved access with compassionate pricing and streamlined docs, enhancing corporate reputation and retention in medical channels.

Further Reading

For context on organisational priorities and values that underpin these campaigns see Mission, Vision & Core Values of Aurora.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE